We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Atriva Therapeutics GmbH Logo

Atriva Therapeutics GmbH

Atriva Therapeutics’ mission is to develop an antiviral and immunomodulatory therapy platform against severe respiratory and systemic diseases with a high unmet medical need induced by RNA viruses, e.g., influenza, COVID-19, RSV (Respiratory Syncytial Virus) and Dengue.

Latest Atriva Therapeutics GmbH Content

Sorry, there is currently no content for this section